Klinika Nemoci Plicnich a Tuberkulozy
About Klinika Nemoci Plicnich a Tuberkulozy
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Vertex Pharmaceuticals Incorporated
2
Ferring Pharmaceuticals
1
Verona Pharma plc
1
Clinical Trials at Klinika Nemoci Plicnich a Tuberkulozy
During the past decade, Klinika Nemoci Plicnich a Tuberkulozy conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults
2017-07-27
2019-10-31
Completed
302
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
2020-09-29
2022-12-02
Completed
763
A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF)
2021-01-18
2022-07-14
Completed
69
A Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor in Participants With Cystic Fibrosis (CF)
2022-01-14
2022-12-20
Completed
86
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinika Nemoci Plicnich a Tuberkulozy"
#1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Klinika Nemoci Plicnich a Tuberkulozy
According to Clinical.Site data, the most researched conditions in "Klinika Nemoci Plicnich a Tuberkulozy" are
"Cystic Fibrosis" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Nocturia" (1 trials). Many other conditions were trialed in "Klinika Nemoci Plicnich a Tuberkulozy" in a lesser frequency.
Clinical Trials Intervention Types at Klinika Nemoci Plicnich a Tuberkulozy
Most popular intervention types in "Klinika Nemoci Plicnich a Tuberkulozy" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "ELX/TEZ/IVA" (2 trials), "IVA" (2 trials), "Desmopressin" (1 trials), "Ensifentrine" (1 trials) and "FE 201836" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinika Nemoci Plicnich a Tuberkulozy
The vast majority of trials in "Klinika Nemoci Plicnich a Tuberkulozy" are
4 trials for "All" genders.
Clinical Trials Status at Klinika Nemoci Plicnich a Tuberkulozy
Currently, there are NaN active trials in "Klinika Nemoci Plicnich a Tuberkulozy".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Klinika Nemoci Plicnich a Tuberkulozy,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinika Nemoci Plicnich a Tuberkulozy, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".